Want to see AU:CSX full AI Analyst Report?
Top Page
CleanSpace Holdings Ltd.
(Sydney:CSX)
Select Model
Select Model
Rating:46Neutral
Price Target:
AU$0.39
▼(-42.35% Downside)
Action:Reiterated
Date:06/13/26
The score is primarily weighed down by weak financial performance—ongoing losses, negative returns, and poor cash flow trends—along with a generally bearish technical setup (below key moving averages and negative MACD). Valuation is relatively neutral (P/E 17.5) but does not offset the fundamental and momentum risks.
Positive Factors
High gross margins
A 74.8% gross margin indicates structurally high product-level profitability from pricing and cost dynamics. That margin buffer supports future operating leverage as revenue scales, enabling the company to invest in channels, R&D or margin-improving initiatives while absorbing fixed costs.
Negative Factors
Persistent unprofitability
Ongoing negative EBIT and net margins indicate the business has not yet converted healthy gross margins into operating profitability. Persistent operating losses require continued funding, limit reinvestment from earnings, and raise execution risk around reaching sustainable profit levels.
Read all positive and negative factors
Positive Factors
Negative Factors
High gross margins
A 74.8% gross margin indicates structurally high product-level profitability from pricing and cost dynamics. That margin buffer supports future operating leverage as revenue scales, enabling the company to invest in channels, R&D or margin-improving initiatives while absorbing fixed costs.
Read all positive factors
CleanSpace Holdings Ltd. (CSX) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$31.74M
Dividend YieldN/A
Average Volume (3M)39.59K
Price to Earnings (P/E)17.7
Beta (1Y)0.54
Revenue Growth17.32%
EPS GrowthN/A
CountryAU
Employees55
SectorHealthcare
Sector Strength45
IndustryMedical - Devices
Share Statistics
EPS (TTM)0.02
Shares Outstanding79,351,524
10 Day Avg. Volume29,005
30 Day Avg. Volume39,591
Financial Highlights & Ratios
PEG Ratio1.00
Price to Book (P/B)2.11
Price to Sales (P/S)2.05
P/FCF Ratio40.19
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)<0.01
Revenue Forecast (FY)AU$22.70M
CleanSpace Holdings Ltd. Business Overview & Revenue Model
Company Description
CleanSpace Holdings Limited is a global enterprise focused on the design, manufacturing, and sale of personal respiratory protective equipment and related services. The company's advanced solutions serve healthcare professionals and a wide array o...
How the Company Makes Money
CleanSpace Holdings Ltd. primarily makes money by selling respiratory protection hardware and related components through distribution and channel partners to end customers that require respiratory PPE. Key revenue streams include: (1) sales of Cle...
CleanSpace Holdings Ltd. Financial Statement Overview
Summary
Income Statement
45
Neutral
Balance Sheet
55
Neutral
Cash Flow
40
Negative
| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 20.66M | 19.76M | 15.72M | 12.09M | 13.36M | 49.93M |
| Gross Profit | 9.47M | 14.78M | 11.36M | -5.16M | 9.75M | 40.27M |
| EBITDA | -606.47K | -824.55K | -3.49M | -10.55M | -14.10M | 17.15M |
| Net Income | 1.76M | -478.28K | -3.13M | -8.13M | -11.28M | 11.39M |
Balance Sheet | ||||||
| Total Assets | 26.92M | 27.57M | 26.05M | 28.98M | 38.36M | 50.72M |
| Cash, Cash Equivalents and Short-Term Investments | 9.83M | 10.47M | 9.76M | 12.16M | 24.30M | 38.24M |
| Total Debt | 2.89M | 4.54M | 3.45M | 4.00M | 4.13M | 4.38M |
| Total Liabilities | 5.62M | 8.41M | 6.95M | 7.02M | 8.60M | 9.99M |
| Stockholders Equity | 21.30M | 19.16M | 19.10M | 21.96M | 29.75M | 40.73M |
Cash Flow | ||||||
| Free Cash Flow | 1.78M | 1.01M | -1.76M | -11.97M | -13.60M | 11.73M |
| Operating Cash Flow | 1.95M | 1.11M | -1.73M | -11.96M | -13.00M | 13.46M |
| Investing Cash Flow | -1.17M | -778.38K | 2.00M | 7.06M | -628.00K | -14.18M |
| Financing Cash Flow | -461.86K | -559.87K | -637.10K | -211.49K | -357.95K | 16.19M |
CleanSpace Holdings Ltd. Technical Analysis
Neutral
0.68
Price Trends
0.40
Positive
0.46
Negative
0.58
Negative
Market Momentum
<0.01
Negative
53.81
Neutral
61.11
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:CSX, the sentiment is Neutral. The current price of 0.68 is above the 20-day moving average (MA) of 0.38, above the 50-day MA of 0.40, and above the 200-day MA of 0.58, indicating a neutral trend. The MACD of <0.01 indicates Negative momentum. The RSI at 53.81 is Neutral, neither overbought nor oversold. The STOCH value of 61.11 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for AU:CSX.
CleanSpace Holdings Ltd. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
49 Neutral | AU$33.78M | -3.98 | -98.14% | ― | 14.88% | 35.94% | |
46 Neutral | AU$31.74M | 17.70 | 8.71% | ― | 17.32% | ― | |
45 Neutral | AU$18.30M | -0.42 | -165.13% | ― | 23.30% | -14.29% | |
44 Neutral | AU$140.83M | -12.89 | -70.29% | ― | ― | -62.15% | |
42 Neutral | AU$63.03M | -3.20 | -54.48% | ― | 17.24% | -20.00% | |
40 Underperform | AU$23.94M | -1.77 | -180.06% | ― | 74.74% | 4.32% |
* Healthcare Sector Average
AU:CSX
CleanSpace Holdings Ltd.
0.40
-0.12
-23.08%
AU:IPD
Impedimed Limited
0.01
-0.02
-60.00%
AU:CYC
Cyclopharm Limited
0.50
-0.41
-45.05%
AU:MX1
Micro-X Ltd.
0.03
-0.02
-36.00%
AU:EMV
EMvision Medical Devices Ltd.
1.52
-0.23
-12.93%
AU:CBL
Control Bionics Ltd.
0.08
0.05
182.76%
CleanSpace Holdings Ltd. Corporate Events
CleanSpace flags softer FY26 growth but backs long-term respirator demand
May 26, 2026
CleanSpace Holdings has warned that challenging trading conditions and delays in certifying new products in Australia, the U.K. and the U.S. will limit FY26 revenue growth to the low single digits. Demand has been further dampened by macroeconomic...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.